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ABSTRACT
 
This paper discusses recent advances that have been made
in the ﬁeld of psychometrics, speciﬁcally, the application
of Rasch analysis to the instrument development process.
It emphasizes the importance of assessing the fundamen-
tal scaling properties of an instrument prior to consider-
ation of traditional psychometric indicators. The paper
introduces Rasch analysis and shows how it has been
applied in the development of needs-based measures in
order to ensure that they provide unidimensional meas-
urement. By ensuring that scales are based on the same
measurement model and that they ﬁt the Rasch model it is
possible for QoL scores to be compared across diseases by
means of cocalibration and item banking.
Keywords: classical test theory, differential item func-
tioning, needs-based quality of life, Rasch analysis,
undimensionality.
 
As long as primitive counts and raw scores are rou-
tinely mistaken for measures by our colleagues in
social, educational, and health research, there is no
hope of their professional activities ever developing
into a reliable or useful science [1].
A crucial aspect of the application of the needs
model is that it has been allied with the most
advanced psychometric methods. This paper argues
the case for the use of Rasch analysis to ensure that
scales are unidimensional [2], a fundamental
requirement of construct validity [3]. The paper
gives an overview of the nature of Rasch analysis
and shows how it aids valid across-disease compar-
isons of quality of life (QoL) by means of co-
calibration and the development of item banks.
Over the last two decades an analytical approach
has been adopted that is pivotal to both judging
the  quality  of  existing  outcome  instruments  and
in developing new instruments. This approach is
called Rasch analysis, after its originator, a Danish
mathematician. He developed Poisson models for
reading, intelligence, and achievement tests, the last
becoming known as the Rasch model [2]. Rasch
analysis has been employed in the development of
most of the needs-based QoL instruments, to ensure
that the resulting scales are unidimensional. Only
the earliest developed needs-based measures did not
beneﬁt from this approach and studies are under-
way to ensure that earlier measures are updated to
ﬁt the Rasch model [4].
The quest for measurement is an important part
of advancing science, and the type of measurement,
which allows for arithmetic operations such as
addition and subtraction, is known as fundamental
measurement [5]. Most outcome measures used in
health care are ordinal in nature, precluding such
arithmetic operations [6]. Many such measures
focus on attributes that are not directly measurable,
such as pain, self-esteem, or quality of life. These
measures give a “manifest score” of the construct
being measured. Consequently, most outcomes are
expressed as ordinal manifest scores, indicating
some rank on a perceived underlying latent trait.
Although there is a substantial body of nonpara-
metric statistics to analyze such information, the
importance of the calculation of change scores in
clinical trial analysis (and attributes of measure-
ment such as the “effect size” [7]), which require
normally distributed interval-level measurement,
gives urgency to achieving a quality of measurement
that will sustain such arithmetic operations.
In order to achieve such fundamental measure-
ment certain properties are required. These are
reviewed in detail elsewhere [8,9] but essentially
they are:
• the numerical properties of order (one mark on
the ruler represents more or less of the con-
struct than another);
• addition (points on rulers may be added
together); and
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• speciﬁc objectivity (the calibration of the ruler
(item set or questions) is independent of the
persons used to calibrate and vice versa).
Where data ﬁt the Rasch model these properties
are conﬁrmed and fundamental measurement fol-
lows. On a more formal level, the theory of simul-
taneous conjoint measurement [10] provides the
mechanism for translating manifest to latent scores:
Rasch analysis delivers conjoint measurement when
data ﬁt the model.
The Rasch model is a unidimensional model that
has two main assertions:
1. that the easier the item is, the more likely it will
be passed (afﬁrmed); and
2. the more able the patient, the more likely they
will pass (afﬁrm) an item (or do a task) com-
pared to a less able patient.
Unidimensionality is a prerequisite to the summa-
tion of any set of items [3,11,12]. The Rasch model
assumes that the probability of a given patient
“passing” an item or task is a logistic function of
the relative distance between the item location
parameter (the difﬁculty of the task) and the
respondent location parameter (the ability of the
patient), and only a function of that difference.
Expressed formally, this gives:
where 
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q
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 is the probability that patients with abil-
ity 
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 will be able to do item (task) 
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, and 
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 is the item
(task) difﬁculty parameter. The model can be
extended to cope with items with more than two
response categories. From this, the expected pattern
of responses to a set of items or tasks is determined
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. When the observed
response pattern coincides with or does not deviate
greatly from the expected response pattern, the
items ﬁt the measurement model and constitute a
true Rasch scale [13]. Various ﬁt statistics determine
whether or not the data do ﬁt the model, and these
tend to be software dependent, although all work
on the principal of looking at the deviation of the
observed data from the model expectation. Finally,
where there is local independence of items (that is,
no residual associations in the data after the Rasch
trait has been removed), this, taken together with ﬁt
to the model, supports the contention that the scale
is unidimensional [14].
Assuming that the data ﬁt, the Rasch model
transforms them from ordinal scores into interval
level measurement with the logit (log odds unit) as
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the unit of measurement. A logit is the distance
along the line of the variable that increases the odds
of observing the event by a factor of 2.718. There is
a clear relation between the ability–difﬁculty differ-
ence, and the probability of afﬁrming an item or
undertaking a task. For example, where the differ-
ence between a patients’ ability and the item or task
difﬁculty is zero, the probability is 0.5. Where the
difference is 
 
+
 
1 logit (that is, the patient has greater
ability—or more of the trait—than expressed by the
item) the probability is 0.73, or 0.27 if the differ-
ence is 
 
-
 
1.0. Where the difference is 
 
±
 
3 logits then
the probabilities are 0.95 and 0.05, respectively.
Differential Item Functioning (DIF) can also be
examined by ﬁtting data to the Rasch model [15].
Essentially, the scale should work in the same way,
irrespective of the group assessed. Thus, the proba-
bility of being able to do a task, or afﬁrming an
item, for patients at the same level of ability (or, for
example, with the same QoL) should remain the
same across groups. Assessment of DIF can yield
crucial information about the measurement equiva-
lence of an instrument between various cultural
groups [16] but should also be applied across gen-
der and age groups within those cultures.
In comparison with classical test theory, the
Rasch model provides a means of assessing a range
of additional measurement properties, increasing
the information available about a scale’s perform-
ance [17–19]. The model is one of many used in this
way, which are generally subsumed under the rubric
of Item Response Theory (IRT) [20,21]. The Rasch
model is known as the one-parameter model within
this framework, but it has unique properties, which
are crucial to attaining conjoint measurement [22],
a prerequisite for the calculation of change scores
[7].
The Rasch model was readily adopted in rehabil-
itation in the late 1980s [23], as the language of
ability and difﬁculty easily transferred from educa-
tion. Patients undergoing rehabilitation have a
given level of ability. In order to assess this level they
can be presented with a range of tasks requiring dif-
fering degrees of ability. Since then the approach has
become used with a wide range of clinical and diag-
nostic groups [24,25]. All recent needs-based qual-
ity of life instruments are developed using this
approach [26–32].
Given that both patients and items are calibrated
on the same underlying metric trait, the potential
for innovation in measurement is considerable.
Consider for example the current debate about
disease-speciﬁc and generic QoL measures. Where
scales are based on the same theoretical unidimen-
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sional construct, items from different diseases can
be calibrated on the same scale, given that some
items (that are free of DIF by diagnosis) common to
both scales are employed. This provides disease-spe-
ciﬁc and comparative QoL measures by “item bank-
ing” items or questions onto the same underlying
metric [33–35]. Currently this approach, based on
the needs-based model of QoL, is being used to
establish an item bank for disease-speciﬁc QoL
measures in the rheumatic diseases [36–38]. A sim-
ilar exercise is planned for dermatology and links
between these two disease areas could be made pos-
sible by means of the Psoriatic Arthritis Quality of
Life (PSAQoL) measure [37].
The needs-based QoL measures all have the
same theoretical basis, are unidimensional (insofar
as their items ﬁt the Rasch model) and have good
traditional psychometric properties. Not only do
they work as effective outcome measures in clinical
trials but they also offer the potential for allowing
valid comparisons of QoL to be made across dis-
eases [39] and between healthy and diseased popu-
lations [40]. While it has been common practice to
use generic health status measures such as the SF-
36 to make such comparisons, the results have
been both misleading and invalid [39]. This is
because, although a question is expressed in the
same way for all respondents, different types of
patients who have had different experiences inter-
pret it differently. For example, a “yes” response to
a question about feeling tired can represent a very
different response for a healthy person and one
with rheumatoid arthritis. This explains why sur-
prising results are frequently obtained for cross-
disease comparisons. For example, data collected
with the SF-36 suggest both that individuals with
psoriasis have worse scores than patients with
arthritis, cancer, and myocardial infarction [41]
and that such patients have comparable or even
better scores than those experienced by an average
population [42].
 
Summary
 
Only occasionally do we see concerns raised about
inappropriate analysis of data that are erroneously
assumed to be at the interval level [6]. The extent to
which analyses of reliability, validity, and respon-
siveness are compromised by ignoring such assump-
tions is unknown. It is also unknown at present to
what extent the misuse of ordinal manifest scores
compromises the results of clinical trial analyses
when these scores are used to calculate changes
across experimental and control groups. However,
the potential implications should not be underesti-
mated [43–45].
The ability of a scale to provide fundamental
measurement should be established prior to the
more commonly reported psychometric attributes.
Rasch analysis offers a method of ensuring that key
measurement assumptions are tested and, where
data ﬁt the model, arithmetic operations may be
undertaken. It has particular value in the develop-
ment of new measures, speciﬁcally in guiding item
reduction. Traditional methods of item reduction
that rely on item–total correlations and/or indices of
internal consistency can have unfortunate effects on
the sensitivity of measures and their ability to pro-
vide valid scores at the extremes of the construct
range. This is because items at the extreme of the
measurement range are generally discarded because
too many or too few respondents afﬁrm them. In
reality, these “extreme” items may be the most
important in a scale—extending its range of cover-
age of the construct.
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